Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder CancerSarah M H Einerhand, Charlotte S Voskuilen, Elies E Fransen van de Putte, et al.
Frontiers in Oncology|April 23, 2021
Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving ImmunotherapyStefano Trebeschi, Zuhir Bodalal, Nick van Dijk, et al.
Elife|December 20, 2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growthSander Al Palit, Daniel Vis, Suzan Stelloo, et al.
Urologic Oncology|November 13, 2017
Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the futureTom J N Hermans, Charlotte S Voskuilen, Michiel S van der Heijden, et al.
The Journal of Urology|April 9, 2021
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World PracticeAxel S Merseburger, Daniel Castellano, Thomas Powles, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 21, 2019
Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancerLaura S Mertens, Mark A Behrendt, Akash M Mehta, et al.
World Journal of Urology|July 18, 2015
Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatinElisabeth E Fransen van de Putte, Laura S Mertens, Richard P Meijer, et al.
Cancer Medicine|April 29, 2023
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinomaElisabeth G E de Vries, Josef Rüschoff, Martijn Lolkema, et al.
Immuno-Oncology Technology|August 26, 2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapyM Yeghaian, Z Bodalal, T M Tareco Bucho, et al.
European Urology|October 1, 2024
FGFR Inhibition in Urothelial CarcinomaRoger Li, Joshua Linscott, James W F Catto, et al.
Pageof 15